Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.

2021 Restricted Share Award Scheme

2019 Restricted Share Award Scheme

Share Option Scheme

Announcements and Notices - [Overseas Regulatory Announcement - Other]

Overseas Regulatory Announcement: Legend Biotech Corporation Announces The European Commission'S Approval Of Carvykti For Second-Line Treatment Of Patients With Relapsed And Refractory Multiple Myeloma

Genscript Biotech (1548 HK)

2021 Restricted Share Award Scheme

2019 Restricted Share Award Scheme

Share Option Scheme

Overseas Regulatory Announcement: Legend Biotech Corporation Announces The European Commission'S Approval Of Carvykti For Second-Line Treatment Of Patients With Relapsed And Refractory Multiple Myeloma

Form Of Proxy For 2024 Annual General Meeting